Adagene (ADAG) Other Non-Current Assets (2019 - 2025)

Adagene's (ADAG) quarterly Other Non-Current Assets came in at $25.2 billion in Q4 2025, down 69.01% year-on-year from $81.4 billion in Q4 2024, and up 67369023.93% on a QoQ basis from $37440.0 in Q2 2025.

Adagene (ADAG) Other Non-Current Assets (2019 - 2025) Analysis & Trends

Adagene (ADAG) has 7 years of Other Non-Current Assets data on file, last reported at $25.2 billion in Q4 2025.

  • On a quarterly basis, Other Non-Current Assets fell 69.01% year-over-year to $25.2 billion in Q4 2025; TTM through Dec 2025 was $25.2 billion, a 69.01% decrease from a year earlier, with the FY2025 full-year figure at $25.2 billion, down 69.01% from the prior year.
  • Other Non-Current Assets for Q4 2025 stood at $25.2 billion, up from $37440.0 in the prior quarter.
  • Over the last five years, Other Non-Current Assets for ADAG reached as high as $109.6 billion in Q4 2022 and fell as low as $37440.0 in Q2 2025.
  • Historically, Other Non-Current Assets has averaged $48.3 billion across 5 years, with a median of $49.0 billion in 2022.
  • Across the five-year window, Other Non-Current Assets soared 158169513.86% in 2022 and slumped 100.0% in 2024, its largest moves.
  • Year by year, Other Non-Current Assets stood at $69275.0 in 2021, then surged by 158169513.86% to $109.6 billion in 2022, then retreated by 22.53% to $84.9 billion in 2023, then dropped by 4.12% to $81.4 billion in 2024, then slumped by 69.01% to $25.2 billion in 2025.
  • Per Business Quant data, the three most recent Other Non-Current Assets figures were $25.2 billion in Q4 2025, $37440.0 in Q2 2025, and $81.4 billion in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 1.02 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 104.24 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.26 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.13 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 124.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 14.48 Mn
10 Adagene 198.85 Mn 198.85 Mn - 25.22 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 25.22 Bn
Jun 30, 2025 37,440.00
Dec 31, 2024 81.39 Bn
Jun 30, 2024 281,881.00
Dec 31, 2023 84.89 Bn
Jun 30, 2023 108.92 Bn
Dec 31, 2022 109.57 Bn
Jun 30, 2022 72.80 Bn
Dec 31, 2021 69,275.00
Jun 30, 2021 59,569.00
Dec 31, 2020 3.10 Mn
Dec 31, 2019 87,227.00